# reload+after+2024-01-21 17:43:52.323965
address1§28 Liberty Street
address2§39th Floor
city§New York
state§NY
zip§10005
country§United States
phone§646 305 6387
fax§646 882 4228
website§https://beyondspringpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
fullTimeEmployees§73
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Lan  Huang Ph.D.', 'age': 52, 'title': 'Co-Founder, Chairman & CEO', 'yearBorn': 1971, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. G. Kenneth Lloyd', 'age': 79, 'title': 'Chief Scientific Officer', 'yearBorn': 1944, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Linqing  Jia', 'title': 'Co-Founder', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Stephen  Kilmer', 'title': 'Head of Investor Relations', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gregg  Russo', 'title': 'Senior Vice President of Human Resources', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.158
priceToSalesTrailing12Months§26.79453
currency§USD
dateShortInterest§1702598400
forwardEps§-0.47
exchange§NCM
quoteType§EQUITY
shortName§BeyondSpring, Inc.
longName§BeyondSpring Inc.
firstTradeDateEpochUtc§1489069800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§13bae88f-b6da-35bd-a612-d48b2fa6eb85
gmtOffSetMilliseconds§-18000000
recommendationMean§1.0
recommendationKey§strong_buy
quickRatio§5.069
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
